{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T05:16:23Z","timestamp":1739510183806,"version":"3.37.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,13]]},"DOI":"10.7759\/cureus.78932","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:57:06Z","timestamp":1739444226000},"source":"Crossref","is-referenced-by-count":0,"title":["Verona Integron-Encoded Metallo-\u03b2-Lactamase (VIM)-Producing Pseudomonas aeruginosa Pyelonephritis in a Young Adult: A Case Report"],"prefix":"10.7759","author":[{"given":"Gerson","family":"De Freitas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70056-1","article-title":"Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams?","volume":"11","author":"Cornaglia G","year":"2011","unstructured":"Cornaglia G, Giamarellou H, Rossolini GM. Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams?. Lancet Infect Dis. 2011, 11:381-93. 10.1016\/S1473-3099(11)70056-1","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-018-0325-1","article-title":"VIM-positive Pseudomonas aeruginosa in a large tertiary care hospital: matched case-control studies and a network analysis","volume":"7","author":"Voor In 't Holt AF","year":"2018","unstructured":"Voor In 't Holt AF, Severin JA, Hagenaars MB, de Goeij I, Gommers D, Vos MC. VIM-positive Pseudomonas aeruginosa in a large tertiary care hospital: matched case-control studies and a network analysis. Antimicrob Resist Infect Control. 2018, 7:32. 10.1186\/s13756-018-0325-1","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03726-y","article-title":"Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care","volume":"25","author":"Catho G","year":"2021","unstructured":"Catho G, Martischang R, Boroli F, et al.. Outbreak of Pseudomonas aeruginosa producing VIM carbapenemase in an intensive care unit and its termination by implementation of waterless patient care. Crit Care. 2021, 25:301. 10.1186\/s13054-021-03726-y","journal-title":"Crit Care"},{"key":"ref4","article-title":"Metallo-beta-lactamase-producing Pseudomonas aeruginosa in Iran: a systematic review and meta-analysis","volume":"26","author":"Vaez H","year":"2018","unstructured":"Vaez H, Khademi F, Salehi-Abargouei A, Sahebkar A. Metallo-beta-lactamase-producing Pseudomonas aeruginosa in Iran: a systematic review and meta-analysis. Infez Med. 2018, 26:216-25.","journal-title":"Infez Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02447-16","article-title":"Molecular \u03b2-lactamase characterization of gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: efficacies analysed against susceptible and resistant subsets","volume":"61","author":"Mendes RE","year":"2017","unstructured":"Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK. Molecular \u03b2-lactamase characterization of gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: efficacies analysed against susceptible and resistant subsets. Antimicrob Agents Chemother. 2017, 61:287-92. 10.1128\/AAC.02447-16","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2807\/ese.17.45.20311-en","article-title":"Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012","volume":"17","author":"Flateau C","year":"2012","unstructured":"Flateau C, Janvier F, Delacour H, et al.. Recurrent pyelonephritis due to NDM-1 metallo-beta-lactamase producing Pseudomonas aeruginosa in a patient returning from Serbia, France, 2012. Euro Surveill. 2012, 17:20311. 10.2807\/ese.17.45.20311-en","journal-title":"Euro Surveill"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2024.08.022","article-title":"Five-year VIM-producing Pseudomonas aeruginosa outbreak in four Belgian ICUs, an investigation report (2019-2023)","volume":"52","author":"Moretti M","year":"2024","unstructured":"Moretti M, Vanstokstraeten R, Cromb\u00e9 F, et al.. Five-year VIM-producing Pseudomonas aeruginosa outbreak in four Belgian ICUs, an investigation report (2019-2023). Am J Infect Control. 2024, 52:1425-31. 10.1016\/j.ajic.2024.08.022","journal-title":"Am J Infect Control"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-024-07070-6","article-title":"Profile of outer membrane proteins of carbapenem-resistant gram-negative bacilli in Ghana","volume":"18","author":"Codjoe FS","year":"2025","unstructured":"Codjoe FS, Kotey FC, Donkor ES. Profile of outer membrane proteins of carbapenem-resistant gram-negative bacilli in Ghana. BMC Res Notes. 2025, 18:49. 10.1186\/s13104-024-07070-6","journal-title":"BMC Res Notes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.7.1584","article-title":"Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate","volume":"43","author":"Lauretti L","year":"1999","unstructured":"Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999, 43:1584-90. 10.1128\/AAC.43.7.1584","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00397-20","article-title":"Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline","volume":"64","author":"Boyd SE","year":"2020","unstructured":"Boyd SE, Livermore DM, Hooper DC, Hope WW. Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother. 2020, 64:e00397. 10.1128\/AAC.00397-20","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00031-19","article-title":"Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections","volume":"32","author":"Horcajada JP","year":"2019","unstructured":"Horcajada JP, Montero M, Oliver A, et al.. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019, 32:19. 10.1128\/CMR.00031-19","journal-title":"Clin Microbiol Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06389-11","article-title":"Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock","volume":"56","author":"Taccone FS","year":"2012","unstructured":"Taccone FS, Cotton F, Roisin S, Vincent JL, Jacobs F. Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock. Antimicrob Agents Chemother. 2012, 56:2129-31. 10.1128\/AAC.06389-11","journal-title":"Antimicrob Agents Chemother"},{"key":"ref13","article-title":"Detection of multidrug resistant (MDR) and extremely drug resistant (XDR) P. aeruginosa isolated from patients in Tehran, Iran","volume":"10","author":"Saderi H","year":"2015","unstructured":"Saderi H, Owlia P. Detection of multidrug resistant (MDR) and extremely drug resistant (XDR) P. aeruginosa isolated from patients in Tehran, Iran. Iran J Pathol. 2015, 10:265-71.","journal-title":"Iran J Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091126","article-title":"Review of ceftazidime-avibactam for the treatment of infections caused by Pseudomonas aeruginosa","volume":"10","author":"Daikos GL","year":"2021","unstructured":"Daikos GL, da Cunha CA, Rossolini GM, Stone GG, Baillon-Plot N, Tawadrous M, Irani P. Review of ceftazidime-avibactam for the treatment of infections caused by Pseudomonas aeruginosa. Antibiotics (Basel). 2021, 10:1126. 10.3390\/antibiotics10091126","journal-title":"Antibiotics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00751-22","article-title":"Ceftazidime-avibactam plus aztreonam for the treatment of infections by VIM-type-producing gram-negative bacteria","volume":"66","author":"Sempere A","year":"2022","unstructured":"Sempere A, Vi\u00f1ado B, Los-Arcos I, et al.. Ceftazidime-avibactam plus aztreonam for the treatment of infections by VIM-type-producing gram-negative bacteria. Antimicrob Agents Chemother. 2022, 66:e0075122. 10.1128\/aac.00751-22","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/342687-verona-integron-encoded-metallo--lactamase-vim-producing-pseudomonas-aeruginosa-pyelonephritis-in-a-young-adult-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T10:57:10Z","timestamp":1739444230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/342687-verona-integron-encoded-metallo--lactamase-vim-producing-pseudomonas-aeruginosa-pyelonephritis-in-a-young-adult-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.78932","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}